Bilgilendirme: Sürüm Güncellemesi ve versiyon yükseltmesi nedeniyle, geçici süreyle zaman zaman kesintiler yaşanabilir ve veri içeriğinde değişkenlikler gözlemlenebilir. Göstereceğiniz anlayış için teşekkür ederiz.
 

Spectrophotometric Quantitative Determination of Cilazapril and Hydrochlorothiazide in Tablets by Chemometric Methods

dc.contributor.author Baleanu, D
dc.contributor.author Dinç, E
dc.contributor.authorID 56389 tr_TR
dc.contributor.other 01. Çankaya Üniversitesi
dc.contributor.other 02.02. Matematik
dc.contributor.other 02. Fen-Edebiyat Fakültesi
dc.date.accessioned 2020-04-15T20:09:24Z
dc.date.accessioned 2025-09-18T15:45:14Z
dc.date.available 2020-04-15T20:09:24Z
dc.date.available 2025-09-18T15:45:14Z
dc.date.issued 2002
dc.description.abstract Four chemometric methods were applied to simultaneous determination of cilazapril and hydrochlorothiazide in tablets. Classical least-square (CLS), inverse least-square (ILS), principal component regression (PCR) and partial least-squares (PLS) methods do not need any priori graphical treatment of the overlapping spectra of two drugs in a mixture. For all chemometric calibrations a concentration set of the random mixture consisting of the two drugs in 0.1 M HCl and methanol (1:1) was prepared. The absorbance data in the UV-Vis spectra were measured for the 15 wavelength points (from 222 to 276 nm) in the spectral region 210-290 nm considering the intervals of Deltalambda = 4 nm. The calibration of the investigated methods involves only absorbance and concentration data matrices. The developed calibrations were tested for the synthetic mixtures consisting of two drugs and using the Maple V software the chemometric, calculations were performed. The results of the methods were compared each other as well as with HPLC method and a good agreement was found. (C) 2002 Elsevier Science B.V. All rights reserved. en_US
dc.description.publishedMonth 10
dc.identifier.citation Dinç, E.; Baleanu, Dumitru, "Spectrophotometric quantitative determination of cilazapril and hydrochlorothiazide in tablets by chemometric methods" Journal Of Pharmaceutical And Biomedical Analysis, Vol.30, No.3, pp.715-723, (2002). en_US
dc.identifier.doi 10.1016/S0731-7085(02)00359-X
dc.identifier.issn 0731-7085
dc.identifier.scopus 2-s2.0-0037201710
dc.identifier.uri https://doi.org/10.1016/S0731-7085(02)00359-X
dc.identifier.uri https://hdl.handle.net/20.500.12416/14534
dc.language.iso en en_US
dc.publisher Pergamon-elsevier Science Ltd en_US
dc.relation.ispartof 12th International Symposium on Pharmaceutical and Biomedical Analysis -- MAY 13-16, 2001 -- MONTEREY, CALIFORNIA en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Chemometric Methods en_US
dc.subject Quantitative Determination en_US
dc.subject Cilazapril en_US
dc.subject Hydrochlorothiazide en_US
dc.subject Tablets en_US
dc.title Spectrophotometric Quantitative Determination of Cilazapril and Hydrochlorothiazide in Tablets by Chemometric Methods en_US
dc.title Spectrophotometric quantitative determination of cilazapril and hydrochlorothiazide in tablets by chemometric methods tr_TR
dc.type Conference Object en_US
dspace.entity.type Publication
gdc.author.institutional Baleanu, Dumitru
gdc.author.scopusid 7003965179
gdc.author.scopusid 7005872966
gdc.author.wosid Baleanu, Dumitru/B-9936-2012
gdc.author.wosid Dinç, Erdal/Aah-6311-2020
gdc.description.department Çankaya University en_US
gdc.description.departmenttemp Ankara Univ, Fac Pharm, Dept Analyt Chem, TR-06100 Ankara, Turkey; Univ Cankaya, Fac Arts & Sci, Dept Math & Comp Sci, TR-06530 Ankara, Turkey; Inst Space Sci, Natl Inst Laser Plasma & Radiat Phys, R-76911 Bucharest, Romania en_US
gdc.description.endpage 723 en_US
gdc.description.issue 3 en_US
gdc.description.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 715 en_US
gdc.description.volume 30 en_US
gdc.description.woscitationindex Conference Proceedings Citation Index - Science - Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.openalex W2076931643
gdc.identifier.pmid 12367697
gdc.identifier.wos WOS:000178826400035
gdc.openalex.fwci 3.39336956
gdc.openalex.normalizedpercentile 0.91
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 38
gdc.plumx.crossrefcites 27
gdc.plumx.mendeley 26
gdc.plumx.newscount 1
gdc.plumx.pubmedcites 4
gdc.plumx.scopuscites 68
gdc.scopus.citedcount 68
gdc.wos.citedcount 59
relation.isAuthorOfPublication f4fffe56-21da-4879-94f9-c55e12e4ff62
relation.isAuthorOfPublication.latestForDiscovery f4fffe56-21da-4879-94f9-c55e12e4ff62
relation.isOrgUnitOfPublication 0b9123e4-4136-493b-9ffd-be856af2cdb1
relation.isOrgUnitOfPublication 26a93bcf-09b3-4631-937a-fe838199f6a5
relation.isOrgUnitOfPublication 28fb8edb-0579-4584-a2d4-f5064116924a
relation.isOrgUnitOfPublication.latestForDiscovery 0b9123e4-4136-493b-9ffd-be856af2cdb1

Files